Cargando…

Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple Interactions

Accumulating evidence links obesity with low-grade inflammation which may originate from adipose tissue that secretes a plethora of pro- and anti-inflammatory cytokines termed adipokines. Adiponectin and leptin have evolved as crucial signals in many obesity-related pathologies including non-alcohol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adolph, Timon E., Grander, Christoph, Grabherr, Felix, Tilg, Herbert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578039/ https://www.ncbi.nlm.nih.gov/pubmed/28758929 http://dx.doi.org/10.3390/ijms18081649

Ejemplares similares

Gut Dysfunction and Non-alcoholic Fatty Liver Disease
por: Grabherr, Felix, et al.
Publicado: (2019)

Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options
por: Grander, Christoph, et al.
Publicado: (2023)

MAFLD: what 2 years of the redefinition of fatty liver disease has taught us
por: Grabherr, Felix, et al.
Publicado: (2022)

Dimethyl fumarate ameliorates hepatic inflammation in alcohol related liver disease
por: Sangineto, Moris, et al.
Publicado: (2020)

The role of gut vascular barrier in experimental alcoholic liver disease and A. muciniphila supplementation
por: Grander, Christoph, et al.
Publicado: (2020)

24-Norursodeoxycholic acid ameliorates experimental alcohol-related liver disease and activates hepatic PPARγ
por: Grander, Christoph, et al.
Publicado: (2023)

Weight Loss Induced by Bariatric Surgery Restricts Hepatic GDF15 Expression
por: Adolph, Timon E., et al.
Publicado: (2018)

Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease
por: Sangineto, Moris, et al.
Publicado: (2022)

Using Infodemiology Metrics to Assess Public Interest in Liver Transplantation: Google Trends Analysis
por: Effenberger, Maria, et al.
Publicado: (2021)

Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade
por: Tilg, Herbert, et al.
Publicado: (2021)

Systemic inflammation as fuel for acute liver injury in COVID-19
por: Effenberger, Maria, et al.
Publicado: (2021)

Microbiota, type 2 diabetes and non-alcoholic fatty liver disease: protocol of an observational study
por: Motta, Benedetta M., et al.
Publicado: (2019)

Liver stiffness by transient elastography accompanies illness severity in COVID-19
por: Effenberger, Maria, et al.
Publicado: (2020)

The Correlation Between Serum Adipokines and Liver Cell Damage in Non-Alcoholic Fatty Liver Disease
por: Jamali, Raika, et al.
Publicado: (2016)

Obesity as the common soil of non‐alcoholic fatty liver disease and diabetes: Role of adipokines
por: Hui, Elaine, et al.
Publicado: (2013)

Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Nier, Anika, et al.
Publicado: (2020)

Determining the association between adipokine expression in multiple tissues and phenotypic features of non-alcoholic fatty liver disease in obesity
por: Wolfs, M G M, et al.
Publicado: (2015)

Adipokines in Non-Alcoholic Fatty Liver Disease: Are We on the Road toward New Biomarkers and Therapeutic Targets?
por: Francisco, Vera, et al.
Publicado: (2022)

Editorial: The roles and mechanisms of hepatokines, adipokines and myokines in the development of non-alcoholic fatty liver disease (NAFLD)
por: Lu, Yan
Publicado: (2022)

The interplay between Th17 and T-regulatory responses as well as adipokines in the progression of non-alcoholic fatty liver disease
por: Świderska, Magdalena, et al.
Publicado: (2017)

Association of pro-inflammatory cytokines, adipokines & oxidative stress with insulin resistance & non-alcoholic fatty liver disease
por: Kumar, Ramesh, et al.
Publicado: (2012)

Reversal of murine alcoholic steatohepatitis by pepducin-based functional blockade of interleukin-8 receptors
por: Wieser, Verena, et al.
Publicado: (2017)

EP1272: DIETARY LIPIDS FUEL METABOLIC ENTERITIS IN CROHN'S DISEASE
por: Schwärzler, Julian, et al.
Publicado: (2022)

A gut bacterial signature in blood and liver tissue characterizes cirrhosis and hepatocellular carcinoma
por: Effenberger, Maria, et al.
Publicado: (2023)

Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease
por: Boutari, Chrysoula, et al.
Publicado: (2018)

Pro-Inflammatory Adipokine and Cytokine Profiles in the Saliva of Obese Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)—A Pilot Study
por: Zyśk, Beata, et al.
Publicado: (2023)

NAD metabolism fuels human and mouse intestinal inflammation
por: Gerner, Romana R, et al.
Publicado: (2018)

Calprotectin: from biomarker to biological function
por: Jukic, Almina, et al.
Publicado: (2021)

Cord Blood Adipokines and Lipids and Adolescent Nonalcoholic Fatty Liver Disease
por: Simpson, Joy, et al.
Publicado: (2016)

Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease
por: Li, Xiaoyan, et al.
Publicado: (2020)

Coronary atherosclerosis profile in patients with end-stage liver disease prior to liver transplantation due to alcoholic fatty liver: a coronary CTA study
por: Steinkohl, Fabian, et al.
Publicado: (2020)

Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease()
por: Khambu, Bilon, et al.
Publicado: (2018)

Non-alcoholic fatty liver disease
por: Neuschwander-Tetri, Brent A.
Publicado: (2017)

Non-alcoholic fatty liver disease
por: Sattar, Naveed, et al.
Publicado: (2014)

Obesity interacts with hyperuricemia on the severity of non-alcoholic fatty liver disease
por: Zhou, Mimi, et al.
Publicado: (2021)

Oxidation-Specific Epitopes in Non-Alcoholic Fatty Liver Disease
por: Hendrikx, Tim, et al.
Publicado: (2020)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
por: Foroughi, Mehdi, et al.
Publicado: (2016)

Alcohol? Not for Non-alcoholic Fatty Liver Disease Patients
por: Cainelli, Francesca, et al.
Publicado: (2020)

The genetic interactions between non-alcoholic fatty liver disease and cardiovascular diseases
por: Chew, Nicholas W.S., et al.
Publicado: (2022)

Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown
por: Iacob, Simona Alexandra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ttjiqimgufcemrl9ll8d90i7hc